亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

PEG‐rhG‐CSF for prophylaxis of neutropenia after chemotherapy in patients with non–small cell lung cancer: A multicenter, prospective, randomized study

作者
Xusheng Sun,Zhe Wang,Shu‐Hua Ren,He‐Lin Zhang,Lijun Liu,Hong‐Bo Du,Xiaowei Liu,Jun‐Feng Liu
出处
期刊:Thoracic Cancer [Wiley]
卷期号:13 (17): 2429-2435 被引量:11
标识
DOI:10.1111/1759-7714.14544
摘要

BACKGROUND: To evaluate the efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in preventing neutropenia during multiple cycles of chemotherapy in patients with non-small cell lung cancer (NSCLC). METHOD: /L. The primary endpoint was the incidence of grade 3/4 neutropenia. Secondary endpoints included the incidence and duration of grade 3/4 neutropenia in each cycle, the incidence of febrile neutropenia (FN), delay rate of chemotherapy, prolonged time of chemotherapy, and safety. RESULTS: Between January 2019 and July 2021, 130 patients were enrolled (treatment group: n = 87, control group: n = 43). The incidence of grade 3/4 neutropenia in the treatment group was significantly lower than that in the control group (1.15% vs. 11.63%, p < 0.05). The mean duration of grade 3/4 neutropenia for the treatment and control group was 2.00 and 3.75 days, respectively. There were no statistical differences in the incidence of FN, delay rate of chemotherapy, prolonged time of chemotherapy, and antibiotic use between the two groups (all p > 0.05). Adverse events were reported in 47.13% of patients in the treatment group and 48.84% patients in the control group. CONCLUSIONS: Primary prophylactic treatment with PEG-rhG-CSF could reduce the incidence of neutropenia in patients with NSCLC during multiple cycles of chemotherapy, with acceptable safety and tolerability.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
3秒前
A水暖五金批发张哥完成签到,获得积分10
3秒前
Ni完成签到 ,获得积分10
4秒前
云墨完成签到 ,获得积分10
4秒前
5秒前
椰子云发布了新的文献求助10
7秒前
学术雷锋发布了新的文献求助10
10秒前
Moon完成签到 ,获得积分10
14秒前
天真的乐驹完成签到 ,获得积分10
18秒前
李健的小迷弟的应助被郦稀采纳,获得10
18秒前
Moon关注了科研通微信公众号
18秒前
19秒前
乐康完成签到,获得积分10
19秒前
22秒前
复杂惜珊完成签到,获得积分10
29秒前
cx完成签到,获得积分10
34秒前
机灵伟诚完成签到,获得积分10
34秒前
学霸业的应助被纯情的阁采纳,获得10
36秒前
极限001的应助被纯情的阁采纳,获得50
36秒前
Maestro_S的应助被纯情的阁采纳,获得10
36秒前
Nikkie2411的应助被纯情的阁采纳,获得10
36秒前
39秒前
40秒前
369ninja的应助被科研通管家采纳,获得10
42秒前
丘比特的应助被科研通管家采纳,获得10
42秒前
手打鱼丸完成签到 ,获得积分10
42秒前
42秒前
完美世界的应助被科研通管家采纳,获得10
42秒前
莫名乐乐完成签到,获得积分10
42秒前
FashionBoy的应助被科研通管家采纳,获得10
42秒前
SciGPT的应助被科研通管家采纳,获得10
42秒前
Akim的应助被纯情的阁采纳,获得10
42秒前
null的应助被科研通管家采纳,获得10
42秒前
43秒前
隐形曼青的应助被纯情的阁采纳,获得10
43秒前
null的应助被科研通管家采纳,获得10
43秒前
wanci的应助被科研通管家采纳,获得30
43秒前
大个的应助被纯情的阁采纳,获得30
43秒前
43秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158598
求助须知:如何正确求助?哪些是违规求助? 9554358
关于积分的说明 21719087
捐赠科研通 7748128
什么是DOI,文献DOI怎么找? 3427032
关于科研通互助平台的介绍 2551902
邀请新用户注册赠送积分活动 2471277